Klement, Rainer J. http://orcid.org/0000-0003-1401-4270
Sweeney, Reinhart A.
Article History
Received: 28 January 2022
Accepted: 30 March 2022
First Online: 2 May 2022
Declarations
:
: R.J. Klement has received an honorarium from the company vitaflo for giving a talk about the objectives and preliminary results of the KETOCOMP study. R.J. Klement and R.A. Sweeney follow a KD occasionally. No other potential conflicts of interest, in particular no financial conflicts of interest, exist. The companies providing product samples for this study had no influence on the design, data collection, or analysis, and none of the authors has any business relationship with them.
: The study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. The protocol was registered on August 6, 2015, under ClinicalTrials.gov identifier NCT02516501 after study approval was granted by the ethics committee of the Bavarian Medical Association (<i>Landesaerztekammer Bayern</i>). Informed consent was obtained from all individual participants included in the study.
Free to read: This content has been made available to all.